LumiThera Completes Patient Enrollment In the LIGHTSITE III Clinical Study
The randomized, multi-center study, LIGHTSITE III, enrolled the last patient at the Byers Eye Institute at Stanford University in Palo Alto, CA with Principal Investigator, Diana Do, M.D.
Kaia Health Unveils Complete Musculoskeletal Care Solution with Kaia Gateway and Premium Partners
Kaia Health’s digital MSK program has already treated 450,000 patients to date.
Tamara Elias, M.D., Joins BehaVR, Inc. Board of Directors
Tamara Elias currently serves as Vice President and Head of Global Partnerships & Innovation at Merck & Co., Inc.
Vascular Dynamics Reports: Positive Preliminary Clinical Trial Results Reported for Their Novel Heart Failure Treatment Technology
Horst Sievert, MD, Director of the CardioVascular Center in Frankfurt, Germany, and Tamaz Shaburishvili, MD, Head of the Cardiovascular Clinic at Tbilisi Heart and Vascular Clinic in Tbilisi, Georgia, shared preliminary results of the clinical trial as part of a CSI Focus D-HF webinar presented last week.